...
首页> 外文期刊>Addiction >INTRANASAL NALOXONE SOON TO BECOME PART OF EVOLVING CLINICAL PRACTICE AROUND OPIOID OVERDOSE PREVENTION
【24h】

INTRANASAL NALOXONE SOON TO BECOME PART OF EVOLVING CLINICAL PRACTICE AROUND OPIOID OVERDOSE PREVENTION

机译:鼻腔内纳洛酮将很快成为阿片类药物过量预防周围临床实践的一部分

获取原文
获取原文并翻译 | 示例

摘要

Naloxone is a life-saving drug, but some current practices involving intransal admsinistration are questionable. However, recent developments mean at least one intranasal preparation is approved by the US Food and Drug Administration addressing some of these concerns. Nevertheless, instranasal forms need to be cheap and should not delay upscaling the use of other forms where intranasal naloxone is not yet approved.
机译:纳洛酮是一种挽救生命的药物,但目前涉及经内给药的一些做法值得怀疑。但是,最近的事态发展意味着至少一种鼻内制剂已获得美国食品和药物管理局的批准,可以解决其中的一些问题。然而,鼻内形式需要便宜,并且在鼻内纳洛酮尚未得到批准的情况下,不应延误扩大其他形式的使用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号